Results 1 to 10 of about 163,209 (266)

Atopic Dermatitis [PDF]

New England Journal of Medicine, 2021
A) Pink scaling plaques and erythematous erosions in the antecubital fossae of a 6-year-old White boy. B) Violaceous, hyperpigmented, nummular plaques on the back and extensor surface of the right arm of a 16-month-old Black girl. C) Atopic dermatitis and follicular prominence/accentuation on the neck of a young Black girl.
Sonja Ständer
exaly   +7 more sources

Seborrheic dermatitis [PDF]

The Journal of Family Practice, 2021
THE COMPARISONA Seborrheic dermatitis in a woman with brown-gray greasy scale, as well as petaloid papules and plaques that are especially prominent in the nasolabial folds.B Seborrheic dermatitis in a man with erythema, scale, and mild postinflammatory hypopigmentation that are especially prominent in the nasolabial folds.C Seborrheic dermatitis in a ...
Candrice R, Heath, Richard P, Usatine
openaire   +4 more sources

Guidelines for treatment of atopic dermatitis [PDF]

Liječnički vjesnik, 2022
Atopic dermatitis is a common, chronically recurrent inflammatory skin disease characterized by a complex etiopathogenesis and a variable clinical phenotype.
Suzana Ljubojević Hadžavdić, Nives Pustišek, Liborija Lugović Mihić, Suzana Ožanić Bulić, Neira Puizina-Ivić, Sandra Peternel, Melita Vukšić Polić, Sandra Marinović Kulišić, Ružica Jurakić Tončić, Slobodna Murat-Sušić, Karmela Husar, Mihael Skerlev, Ivana Martinac Ciglar,, Tomislav Duvančić, Vedrana Bulat, Iva Dediol, Ranka Ivanišević, Iva Bojčić, Ines Brajac, Igor Kuric, Lena Kotrulja, Lucija Tomić Babić, Gordana Krnjević-Pezić, Vlatka Čavka, Andrija Stanimirović, Zrinka Bukvić Mokos, Mirna Šitum, Branka Marinović   +27 more
doaj   +1 more source

Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry

Acta Dermato-Venereologica, 2023
Clinical trials showed that upadacitinib, a selective Janus kinase-1 inhibitor, is effective for treatment of moderate-to-severe atopic dermatitis. However, daily practice studies are limited.
Celeste M. Boesjes, Liana F. van der Gang, Nicolaas P.A. Zuithoff, Daphne S. Bakker, Lotte S. Spekhorst, Inge Haeck, Marijke Kamsteeg, Marlies de Graaf, Marjolein S. de Bruin-Weller   +8 more
doaj   +1 more source

Oral food challenges in children [PDF]

Korean Journal of Pediatrics, 2011
Many patients assume that allergic reactions against foods are responsible for triggering or worsening their allergic symptoms. Therefore, it is important to identify patients who would benefit from an elimination diet, while avoiding unnecessary dietary
Hye Yung Yum, Hyeon Jong Yang, Kyung Won Kim, Tae Won Song, Woo Kyung Kim, Jung Hee Kim, Kang Mo Ahn, Hyun Hee Kim, Soo Young Lee, Bok Yang Pyun   +9 more
doaj   +1 more source

Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry

Acta Dermato-Venereologica, 2021
Dupilumab treatment improves signs, symptoms, and quality of life in patients with moderate-to-severe atopic dermatitis. This study evaluated the impact of dupilumab treatment on absenteeism, presenteeism, and related costs in a large multi-centre cohort
Lieneke F.M. Ariëns, Daphne S. Bakker, Lotte S. Spekhorst, Jorien van der Schaft, Judith L. Thijs, Inge Haeck, Annebeth E. Flinterman, Marijke Kamsteeg, Marie L.A. Schuttelaar, Marjolein S. De Bruin-Weller   +9 more
doaj   +1 more source

High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease

Clinical and Translational Allergy, 2023
Background The patho‐mechanism of ocular surface disease (OSD) in dupilumab‐treated atopic dermatitis (AD) patients remains unclear. The aim of this study is to measure dupilumab levels in tear fluid and serum, and relate these findings to the severity ...
Roselie Achten, Judith Thijs, Marlot van derWal, Chantal vanLuijk, Matthijs vanLuin, Mohsin el Amrani, Edward Knol, Eveline Delemarre, Constance den Hartog Jager, Marlies deGraaf, Daphne Bakker, Joke deBoer, Femke vanWijk, Marjolein deBruin‐Weller   +13 more
doaj   +1 more source

THE METHOD FOR PREDICTIVE ASSESSMENT OF THE CONDITION OF PATIENTS WITH ATOPIC DERMATITIS AT DIFFERENT STAGES OF THE DISEASE

Сучасний стан наукових досліджень та технологій в промисловості, 2021
The subject of the research is the development of a method for prognostic assessment of the condition of patients with atopic dermatitis at different stages of the disease.
Oleg Avrunin, Alexey Trubitcin, Viktoriia Klymenko   +2 more
doaj   +1 more source

Acne Vulgaris, Atopic Dermatitis and Rosacea: The Role of the Skin Microbiota—A Review

Biomedicines, 2022
The skin harbors a huge number of different microorganisms such as bacteria, fungi and viruses, and it acts as a protective shield to prevent the invasion of pathogens and to maintain the health of the commensal microbiota. Several studies, in fact, have
Giorgia Condrò, Marta Guerini, Michela Castello, Paola Perugini   +3 more
doaj   +1 more source

An Open Trial on the Feasibility and Efficacy of a Mindfulness-Based Intervention with Psychoeducational Elements on Atopic Eczema and Chronic Itch

Psych, 2022
(1) Background: Mindfulness-based interventions (MBI) are psychological group interventions conducted over several weeks. Their effects on reducing stress and improving physical and psychological health have been proven in various clinical populations ...
Julia Harfensteller
doaj   +1 more source